Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease

This publication has 22 references indexed in Scilit:

• Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial
  Yearbook of Cardiology, 2008
• Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization
  American Journal of Health-System Pharmacy, 2007
• A meta-analysis of the association between adherence to drug therapy and mortality
  BMJ, 2006
• Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease
  Circulation, 2006
• Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
  European Heart Journal, 2006
• ACC/AHA Clinical Performance Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non–ST-Elevation Myocardial Infarction)
  Journal of the American College of Cardiology, 2006
• Adherence to Medication
  New England Journal of Medicine, 2005
• Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
  Archives of internal medicine (1960), 2005
• Lipid Management in Patients With Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization
  Archives of internal medicine (1960), 2005
• Use and adherence to beta‐blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
  Pharmacoepidemiology and Drug Safety, 2004